Literature DB >> 22511629

Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways.

Ian S Zagon1, Anna M Campbell, Joseph W Sassani, Patricia J McLaughlin.   

Abstract

PURPOSE: To elucidate the factors in tear production, this study examined the role of endogenous opioids and opioid receptors in spontaneous episodic reduced tear volume.
METHODS: A model of spontaneous episodic decreases in the quantity of tears was characterized in otherwise normal Sprague-Dawley rats using Schirmer's test. A single eye drop of 10(-5) M naltrexone (NTX), 10(-5) M [Met(5)]-enkephalin, or sterile vehicle was administered to one eye. Tear secretion, corneal sensitivity, and corneal morphology were examined in both eyes.
RESULTS: At any given time period, otherwise normal rats were found to have Schirmer test scores with a bimodal distribution (6.5 mm or less, or 7.0 mm or greater). Decreased tear production was detected in male and female rats aged 4 to 24 weeks at least once per animal. The episodes of reduced tear volume ranged from 1 to 7 days. No changes in corneal sensitivity or corneal morphology were observed in any rat. One drop of NTX given to rats with a decrease in tear volume raised levels of tears to scores of 7.0 mm or greater within 1 hour, and increased tear production persisted for at least 48 hours. NTX had no effect on rats with Schirmer scores of 7.0 mm or higher. Topical application of [Met(5)]-enkephalin depressed tear secretion from baseline scores of 9.8 ± 0.6 mm to as low as 4.5 ± 0.7 mm.
CONCLUSIONS: Normal rats experience fluctuations in tear production that can be modulated by opioidergic signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511629      PMCID: PMC3383188          DOI: 10.1167/iovs.11-9051

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

Review 1.  Corneal nerves: structure, contents and function.

Authors:  Linda J Müller; Carl F Marfurt; Friedrich Kruse; Timo M T Tervo
Journal:  Exp Eye Res       Date:  2003-05       Impact factor: 3.467

2.  Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease.

Authors:  Harumitsu Hirata; Ian D Meng
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

3.  Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.

Authors:  T Fujihara; T Murakami; H Fujita; M Nakamura; K Nakata
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-01       Impact factor: 4.799

4.  Presence of nerves and their receptors in mouse and human conjunctival goblet cells.

Authors:  Y Diebold; J D Ríos; R R Hodges; I Rawe; D A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

Review 5.  Opioid modulation of magnocellular neurosecretory cell activity.

Authors:  C H Brown; J A Russell; G Leng
Journal:  Neurosci Res       Date:  2000-02       Impact factor: 3.304

6.  Prevalence of dry eye disease in an elderly Korean population.

Authors:  Sang Beom Han; Joon Young Hyon; Se Joon Woo; Jung Jae Lee; Tae Hui Kim; Ki Woong Kim
Journal:  Arch Ophthalmol       Date:  2011-05

7.  A mouse model of keratoconjunctivitis sicca.

Authors:  Dilek Dursun; Min Wang; Dagoberto Monroy; De-Quan Li; Balakrishna L Lokeshwar; Michael E Stern; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

8.  Why the eye becomes dry: a cornea and lacrimal gland feedback model.

Authors:  W D Mathers
Journal:  CLAO J       Date:  2000-07

9.  Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.

Authors:  Ian S Zagon; Matthew S Klocek; Joseph W Sassani; Patricia J McLaughlin
Journal:  Arch Ophthalmol       Date:  2009-11

10.  Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.

Authors:  Takashi Nagano; Masatsugu Nakamura; Katsuhiko Nakata; Takeshi Yamaguchi; Kenji Takase; Akihiko Okahara; Toshimi Ikuse; Teruo Nishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

View more
  3 in total

Review 1.  The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes-The Lorenz E. Zimmerman Tribute Lecture.

Authors:  Joseph W Sassani; Patricia J Mc Laughlin; Ian S Zagon
Journal:  J Diabetes Res       Date:  2016-09-14       Impact factor: 4.011

2.  Functional anatomy of the lacrimal gland in African black ostrich Struthio camelus domesticus in the embryonic and postnatal period.

Authors:  Joanna Klećkowska-Nawrot; Karolina Goździewska-Harłajczuk; Renata Nowaczyk; Krzysztof Krasucki
Journal:  Onderstepoort J Vet Res       Date:  2015-03-25       Impact factor: 1.792

3.  Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Ian S Zagon
Journal:  J Cell Immunol       Date:  2020
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.